Bisphosphonate-related osteonecrosis of the jaw: background and guidelines for diagnosis, staging and management

Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2006 Oct;102(4):433-41. doi: 10.1016/j.tripleo.2006.06.004. Epub 2006 Jul 31.

Authors

Salvatore L Ruggiero¹, John Fantasia, Eric Carlson

Affiliation

¹ Division of Oral and Maxillofacial Surgery, Long Island Jewish Medical Center, New Hyde Park, NY 11040, USA. ruggiero@lij.edu

PMID: 16997108
DOI: 10.1016/j.tripleo.2006.06.004

No abstract available

MeSH terms

Administration, Oral
Bone Density Conservation Agents / administration & dosage
Bone Density Conservation Agents / adverse effects*
Bone Neoplasms / drug therapy
Bone Neoplasms / secondary
Bone Remodeling / drug effects
Breast Neoplasms / drug therapy
Clinical Protocols
Diagnosis, Differential
Diphosphonates / administration & dosage
Diphosphonates / adverse effects*
Female
Humans
Injections, Intravenous
Jaw Diseases / chemically induced*
Jaw Diseases / pathology
Jaw Diseases / prevention & control
Multiple Myeloma / drug therapy
Oral Surgical Procedures / adverse effects
Osteoclasts / drug effects
Osteonecrosis / chemically induced*
Osteonecrosis / pathology
Osteonecrosis / prevention & control
Osteoporosis / prevention & control
Risk Factors

Substances

Bone Density Conservation Agents
Diphosphonates